Login Register Cart 0
Generic placeholder image

Current Cancer Drug Targets

Editor-in-Chief

ISSN (Print): 1568-0096
ISSN (Online): 1873-5576

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Letter to the Editor

Forkhead Box Protein M1 (FOXM1): Prospective Prognostic Biomarker and Therapeutic Targets in Oral Cancer

Author(s): Baskar Venkidasamy*, Ramkumar Samynathan and Rajakumar Govidasamy

Volume 23, Issue 11, 2023

Published on: 23 June, 2023

Page: [834 - 836] Pages: 3

DOI: 10.2174/1568009623666230531161420

Price: $65

« Previous Next »
[1]
Down, C.F.; Millour, J.; Lam, E.W.F.; Watson, R.J. Binding of FoxM1 to G2/M gene promoters is dependent upon B-Myb. Biochim. Biophys. Acta. Gene Regul. Mech., 2012, 1819(8), 855-862.
[http://dx.doi.org/10.1016/j.bbagrm.2012.03.008] [PMID: 22513242]
[2]
Gu, C.; Jing, X.; Holman, C.; Sompallae, R.; Zhan, F.; Tricot, G.; Yang, Y.; Janz, S. Upregulation of FOXM1 leads to diminished drug sensitivity in myeloma. BMC Cancer, 2018, 18(1), 1152.
[http://dx.doi.org/10.1186/s12885-018-5015-0] [PMID: 30463534]
[3]
Park, Y.Y.; Jung, S.Y.; Jennings, N.B.; Rodriguez-Aguayo, C.; Peng, G.; Lee, S.R.; Kim, S.B.; Kim, K.; Leem, S.H.; Lin, S.Y.; Lopez-Berestein, G.; Sood, A.K.; Lee, J.S. FOXM1 mediates Dox resistance in breast cancer by enhancing DNA repair. Carcinogenesis, 2012, 33(10), 1843-1853.
[http://dx.doi.org/10.1093/carcin/bgs167] [PMID: 22581827]
[4]
Harada, K.; Ferdous, T.; Minami, H.; Mishima, K. Prognostic significance of FOXM1 in oral squamous cell carcinoma patients treated by docetaxel-containing regimens. Mol. Clin. Oncol., 2018, 10(1), 29-36.
[http://dx.doi.org/10.3892/mco.2018.1770] [PMID: 30655974]
[5]
Ferdous, T.; Harada, K.; Ueyama, Y. High expression of FOXM1 is a potential prognostic marker for oral squamous cell carcinoma patients treated with docetaxel-containing regimens. Ann. Oncol., 2016, 27, vi348.
[http://dx.doi.org/10.1093/annonc/mdw376.63]
[6]
Yang, H.; Wen, L.; Wen, M.; Liu, T.; Zhao, L.; Wu, B.; Yun, Y.; Liu, W.; Wang, H.; Wang, Y.; Wen, N. FoxM1 promotes epithelial–mesenchymal transition, invasion, and migration of tongue squamous cell carcinoma cells through a c-Met/AKT-dependent positive feedback loop. Anticancer Drugs, 2018, 29(3), 216-226.
[http://dx.doi.org/10.1097/CAD.0000000000000585] [PMID: 29360662]
[7]
Roh, V.; Hiou-Feige, A.; Misetic, V.; Rivals, J.P.; Sponarova, J.; Teh, M.T.; Ferreira Lopes, S.; Truan, Z.; Mermod, M.; Monnier, Y.; Hess, J.; Tolstonog, G.V.; Simon, C. The transcription factor FOXM1 regulates the balance between proliferation and aberrant differentiation in head and neck squamous cell carcinoma. J. Pathol., 2020, 250(1), 107-119.
[http://dx.doi.org/10.1002/path.5342] [PMID: 31465124]
[8]
Qadir, F.; Aziz, M.A.; Sari, C.P.; Ma, H.; Dai, H.; Wang, X.; Raithatha, D.; Da Silva, L.G.L.; Hussain, M.; Poorkasreiy, S.P.; Hutchison, I.L.; Waseem, A.; Teh, M.T. Transcriptome reprogramming by cancer exosomes: identification of novel molecular targets in matrix and immune modulation. Mol. Cancer, 2018, 17(1), 97.
[http://dx.doi.org/10.1186/s12943-018-0846-5] [PMID: 30008265]
[9]
Luo, Y.D.; Ding, X.; Du, H.M.; Wu, Y.N.; Li, H.Q.; Wu, H.M.; Zhang, X.M. FOXM1 is a novel predictor of recurrence in patients with oral squamous cell carcinoma associated with an increase in epithelial-mesenchymal transition. Mol. Med. Rep., 2019, 19(5), 4101-4108.
[http://dx.doi.org/10.3892/mmr.2019.10094] [PMID: 30942437]
[10]
Ma, X.; Zhang, H.; Li, Q.; Schiferle, E.; Qin, Y.; Xiao, S.; Li, T. FOXM1 Promotes Head and Neck Squamous Cell Carcinoma via Activation of the Linc-ROR/LMO4/AKT/PI3K Axis. Front. Oncol., 2021, 11, 658712.
[http://dx.doi.org/10.3389/fonc.2021.658712] [PMID: 34447693]
[11]
Chen, X.; Chen, J.; Yu, X.; Lin, G.; Chen, T. FOXM1 Promotes Malignant Proliferation of Esophageal Squamous Cell Carcinoma Through Transcriptional Activating CDC6. DNA Cell Biol., 2022, 41(7), 671-682.
[http://dx.doi.org/10.1089/dna.2022.0169] [PMID: 35639418]
[12]
Shrivastava, N.; Wallach, Y.; Li, D.; Thomas, C.; Prystowsky, M.B.; Basu, I.; Guha, C.; Ow, T.J. The role of FOXM1 in senescence suppression and radiation resistance in oral cavity squamous cell carcinoma [abstract]. Proceedings of the American Association for Cancer Research Annual Meeting, 2022.2022 Apr 8-13Philadelphia (PA)
[http://dx.doi.org/10.1158/1538-7445.AM2022-203]
[13]
Zhao, X.; Chen, H.; Qiu, Y.; Cui, L. FAM64A promotes HNSCC tumorigenesis by mediating transcriptional autoregulation of FOXM1. Int. J. Oral Sci., 2022, 14(1), 25.
[http://dx.doi.org/10.1038/s41368-022-00174-4] [PMID: 35538067]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy